论文部分内容阅读
由Theratech公司开发生产的一种睾酮(睾丸素)贴剂最近获美国FDA许可,它将由史克比切姆公司以Androderm商品名进行销售,该药主要贴在男性的腹部、背部、大腿部和手臂等部位,用于性机能不全:性无能、丧失性欲、疲劳等。这些症状长时间继续时,将形成骨质疏松症。一般来说,男性40~50岁开始发生睾酮水平降低,而到了70岁时只有30岁之一半水平。患有性无能、缺少睾酮的男性是可使用Androderm加以调整,但对65岁以上男性必须要调查其原因,否则不能任意服用。美国FDA也以限于65岁以下男
A testosterone (testosterone) patch developed and produced by Theratech Inc., recently licensed by the U.S. FDA, will be marketed under the trade name Androderm by the company Schmidt & Betts, mainly on the abdomen, back and thighs of men And arm and other parts, for sexual insufficiency: impotence, loss of libido, fatigue and so on. When these symptoms continue for a long time, osteoporosis will develop. In general, men develop a reduction in testosterone levels at 40 to 50 years of age, and by the age of 70 are only 30 years of age. Men with impotence and lack of testosterone can be adjusted using Androderm, but men over the age of 65 must investigate the cause, otherwise they can not take it. US FDA is also limited to men under the age of 65